Atonal homolog 1 protein stabilized by tumor necrosis factor α induces high malignant potential in colon cancer cell line

Cancer Science

Volumn 106, Issue 8, 2015, Pages 1000-1007

  Fukushima, Keita ^a   Tsuchiya, Kiichiro ^a   Kano, Yoshihito ^a,b   Horita, Nobukatsu ^a   Hibiya, Shuji ^a   Hayashi, Ryohei ^a,c   Kitagaki, Keisuke ^a   Negi, Mariko ^a   Itoh, Eisaku ^a   Akashi, Takumi ^a   Eishi, Yoshinobu ^a   Oshima, Shigeru ^a   Nagaishi, Takashi ^a   Okamoto, Ryuichi ^a,d   Nakamura, Tetsuya ^a   Watanabe, Mamoru ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TORONTO   (Canada)

^c HIROSHIMA UNIVERSITY   (Japan)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY HOSPITAL   (Japan)

Author keywords

Atonal homolog 1; Cancer stem cells; Colitis associated cancer; Inflammatory bowel disease; Signet ring cell

Indexed keywords

ALDEHYDE DEHYDROGENASE ISOENZYME 1; ATONAL HOMOLOG 1 PROTEIN; BETA ACTIN; CASPASE 3; CASPASE 9; FLUOROURACIL; GLYCOGEN SYNTHASE KINASE 3BETA; HISTONE DEACETYLASE 6; MUCIN 2; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; OXALIPLATIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEASOME; PROTEIN KINASE B; PROTEIN LGR5; PROTEIN TFF3; PYRUVATE DEHYDROGENASE KINASE; RAF PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ATOH1 PROTEIN, HUMAN; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR;

ADULT; ARTICLE; CANCER CELL LINE; CANCER PROGNOSIS; CANCER RESISTANCE; CANCER STEM CELL; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL MIGRATION; COLITIS ASSOCIATED COLORECTAL CANCER; COLON CANCER; COLON CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; INFLAMMATORY BOWEL DISEASE; INTESTINE EPITHELIUM CELL; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN STABILITY; UPREGULATION; COLORECTAL TUMOR; COMPLICATION; INTESTINE MUCOSA; METABOLISM; MIDDLE AGED; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL LINE; WESTERN BLOTTING;

ADULT; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BLOTTING, WESTERN; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; MALE; MIDDLE AGED; NEOPLASTIC STEM CELLS; REAL-TIME POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84939155361     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12703     Document Type: Article

References (28)

1. Ullman TA, Itzkowitz SH. Intestinal inflammation and cancer. Gastroenterology 2011; 140: 1807-16.
2. Castano-Milla C, Chaparro M, Gisbert JP. Systematic review with meta-analysis: the declining risk of colorectal cancer in ulcerative colitis. Aliment Pharmacol Ther 2014; 39: 645-59.
3. Molodecky NA, Soon IS, Rabi DM et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012; 142: 46-54.e42; quiz e30.
4. Oka S, Tanaka S, Chayama K. Detection of nonpolypoid colorectal neoplasia using magnifying endoscopy in colonic inflammatory bowel disease. Gastrointest Endosc Clin N Am 2014; 24: 405-17.
5. Watanabe T, Konishi T, Kishimoto J, Kotake K, Muto T, Sugihara K. Ulcerative colitis-associated colorectal cancer shows a poorer survival than sporadic colorectal cancer: a nationwide Japanese study. Inflamm Bowel Dis 2011; 17: 802-8.
6. Higashi D, Futami K, Ishibashi Y et al. Clinical course of colorectal cancer in patients with ulcerative colitis. Anticancer Res 2011; 31: 2499-504.
7. Yang Q, Bermingham N, Finegold M, Zoghbi H. Requirement of Math1 for secretory cell lineage commitment in the mouse intestine. Science 2001; 294: 2155-8.
8. Zheng X, Tsuchiya K, Okamoto R et al. Suppression of hath1 gene expression directly regulated by hes1 via notch signaling is associated with goblet cell depletion in ulcerative colitis. Inflamm Bowel Dis 2011; 17: 2251-60.
9. Iwasaki M, Tsuchiya K, Okamoto R et al. Longitudinal cell formation in the entire human small intestine is correlated with the localization of Hath1 and Klf4. J Gastroenterol 2011; 46: 191-202.
10. Tsuchiya K, Nakamura T, Okamoto R, Kanai T, Watanabe M. Reciprocal targeting of Hath1 and beta-catenin by wnt glycogen synthase kinase 3 beta in human colon cancer. Gastroenterology 2007; 132: 208-20.
11. Aragaki M, Tsuchiya K, Okamoto R et al. Proteasomal degradation of Atoh1 by aberrant Wnt signaling maintains the undifferentiated state of colon cancer. Biochem Biophys Res Commun 2008; 368: 923-9.
12. Park ET, Oh HK, Gum JR et al. HATH1 expression in mucinous cancers of the colorectum and related lesions. Clin Cancer Res 2006; 12: 5403-10.
13. Kano Y, Tsuchiya K, Zheng X et al. The acquisition of malignant potential in colon cancer is regulated by the stabilization of Atonal homolog 1 protein. Biochem Biophys Res Commun 2013; 432: 175-81.
14. Horita N, Tsuchiya K, Hayashi R et al. Fluorescent labelling of intestinal epithelial cells reveals independent long-lived intestinal stem cells in a crypt. Biochem Biophys Res Commun 2014; 454: 493-9.
15. Bamias G, Dahman MI, Arseneau KO et al. Intestinal-specific TNFalpha overexpression induces Crohn's-like ileitis in mice. PLoS ONE 2013; 8: e72594.
16. Billiet T, Rutgeerts P, Ferrante M, Van Assche G, Vermeire S. Targeting TNF-alpha for the treatment of inflammatory bowel disease. Expert Opin Biol Ther 2014; 14: 75-101.
17. Kim MS, Shutov LP, Gnanasekaran A et al. Nerve growth factor (NGF) regulates activity of nuclear factor of activated T-cells (NFAT) in neurons via the phosphatidylinositol 3-kinase (PI3K)-Akt-glycogen synthase kinase 3beta (GSK3beta) pathway. J Biol Chem 2014; 289: 31349-60.
18. Lee JY, Park MK, Park JH et al. Loss of the polycomb protein Mel-18 enhances the epithelial-mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer. Oncogene 2014; 33: 1325-35.
19. Hales EC, Taub JW, Matherly LH. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of gamma-secretase inhibitor resistant T-cell acute lymphoblastic leukemia. Cell Signal 2014; 26: 149-61.
20. Faurschou A, Gniadecki R. TNF-alpha stimulates Akt by a distinct aPKC-dependent pathway in premalignant keratinocytes. Exp Dermatol 2008; 17: 992-7.
21. Panja A, Goldberg S, Eckmann L, Krishen P, Mayer L. The regulation and functional consequence of proinflammatory cytokine binding on human intestinal epithelial cells. J Immunol 1998; 161: 3675-84.
22. Greten FR, Eckmann L, Greten TF et al. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 2004; 118: 285-96.
23. Samaan MA, Bagi P, Vande Casteele N, D'Haens GR, Levesque BG. An update on anti-TNF agents in ulcerative colitis. Gastroenterol Clin North Am 2014; 43: 479-94.
24. Barker N, van Es JH, Kuipers J et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 2007; 449: 1003-U1.
25. Takahashi H, Ishii H, Nishida N et al. Significance of Lgr5(+ve) cancer stem cells in the colon and rectum. Ann Surg Oncol 2011; 18: 1166-74.
26. Wehkamp J, Chu H, Shen B et al. Paneth cell antimicrobial peptides: topographical distribution and quantification in human gastrointestinal tissues. FEBS Lett 2006; 580: 5344-50.
27. Wehkamp J, Wang G, Kubler I et al. The Paneth cell alpha-defensin deficiency of ileal Crohn's disease is linked to Wnt/Tcf-4. J Immunol 2007; 179: 3109-18.
28. Yui S, Nakamura T, Sato T et al. Functional engraftment of colon epithelium expanded in vitro from a single adult Lgr5 stem cell. Nat Med 2012; 18: 618-23.